BeStock  
Stocks › Medical Devices › INMD

InMode INMD

US equityMarket cap rank #3404Medical Devices
$14.01 +$0.02 (+0.14%)
Pre-market · Oct 8, 8:10 am ET · After hours $13.85 -1.12%
Open$13.91
Prev close$13.99
Day range$13.90 – $14.05
Volume512.0K
Market cap$806.19M
P/E (TTM)11.6
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

Technical signals

Trend readStrong downtrend

1 bullish · 6 bearish of 7 signals

IndicatorValueSignalReading
Price vs 20-day average-2.5%BearishTrading below the 20-day average of $14.37
Price vs 50-day average-5.2%BearishTrading below the 50-day average of $14.78
Price vs 200-day average-2.6%BearishTrading below the 200-day average of $14.39
50-day vs 200-day50d above 200dBullishThe 50-day average is above the 200-day average
RSI (14)30.8BearishMomentum leans negative
MACD (12,26,9)-0.22BearishMACD line is below its signal line
Bollinger band position20%BearishInside the 20-day bands

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

Levels & volatility

Moving averages

AverageLevelPrice vs. it
20-day SMA$14.37-2.5%
50-day SMA$14.78-5.2%
200-day SMA$14.39-2.6%

Recent price levels

LevelPrice
20-day high$14.97
20-day low$13.90
60-day high$15.67
60-day low$13.90
Upper Bollinger band$14.97
Lower Bollinger band$13.76

The 50-day average is currently 2.7% above the 200-day average — consistent with a “golden cross” (bullish) configuration.

30-day volatility11.4%
Average true range1.25% of price
Max drawdown (1y)-23.2%
Volume (10d vs 90d)0.78x

Discussion

No comments yet — be the first to weigh in on INMD.

Leave a comment

Scroll to Top